AAAVX | CAIBX | AAAVX / CAIBX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 10 years | 38 years | - |
Gain YTD | 3.550 | 5.090 | 70% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.18B | 110B | 4% |
Annual Yield % from dividends | 2.36 | 3.28 | 72% |
Returns for 1 year | 11.31 | 12.15 | 93% |
Returns for 3 years | 4.94 | 13.84 | 36% |
Returns for 5 years | 27.44 | 27.82 | 99% |
Returns for 10 years | 60.90 | 35.74 | 170% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FTDZX | 130.03 | -0.76 | -0.58% |
Franklin Biotechnology Discovery Adv | |||
LOGOX | 36.45 | -0.28 | -0.76% |
Scharf Multi-Asset Opportunity Instl | |||
KCVIX | 17.41 | -0.24 | -1.36% |
Knights of Columbus Large Cap Value I | |||
MLAIX | 12.11 | -0.28 | -2.26% |
NYLI Winslow Large Cap Growth Class I | |||
MBCSX | 23.67 | -0.57 | -2.35% |
MassMutual Blue Chip Growth R5 |